Alan Venook

33PUBLICATIONS
169CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedEnvironment and culture
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 14, 2026
A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.

|Sep 04, 2025
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials.

Marco Maria Germani, Beatrice Borelli, Tadayoshi Hashimoto

|Sep 03, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).

Emily K Bergsland, Susan Geyer, Timothy R Asmis

|Apr 25, 2025
Associations between early tumor shrinkage/depth of response and survival from the ARCAD database.

Hideaki Bando, Yuriko Takeda, Toshihiro Misumi

|Apr 16, 2025
Expansion of a bacterial operon during cancer treatment ameliorates fluoropyrimidine toxicity.

Kai R Trepka, Wesley A Kidder, Than S Kyaw

|Mar 08, 2024
HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405.

Francesca Battaglin, Fang-Shu Ou, Xueping Qu

Pageof 6

Frequent Collaborators

12 joint publications

Heinz-Josef Lenz

11 joint publications

Fang-Shu Ou

8 joint publications

Jeffrey A Meyerhardt

8 joint publications

Eileen O'Reilly